Robeco Institutional Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-301
Closed -$20.1K 966
2023
Q4
$20.1K Buy
+301
New +$19.5K ﹤0.01% 1003
2020
Q3
Sell
-14,439
Closed -$711K 941
2020
Q2
$711K Sell
14,439
-10,665
-42% -$575K ﹤0.01% 775
2020
Q1
$1.28M Hold
25,104
0.01% 735
2019
Q4
$1.38M Hold
25,104
﹤0.01% 756
2019
Q3
$1.26M Sell
25,104
-8,296
-25% -$417K ﹤0.01% 760
2019
Q2
$1.68M Sell
33,400
-761,644
-96% -$37M 0.01% 727
2019
Q1
$36.9M Sell
795,044
-43,210
-5% -$2.19M 0.14% 204
2018
Q4
$41.1M Buy
838,254
+528,831
+171% +$30.1M 0.18% 158
2018
Q3
$19.2M Buy
+309,423
New +$18.8M 0.08% 301

Other funds holding EHC

Robeco Institutional Asset Management's EHC Position: Q1 2024 in Review

Robeco Institutional Asset Management sold out of Encompass Health (EHC) in Q1 2024, closing a stake of 301 shares — an estimated $20.1K sold.

Robeco Institutional Asset Management first reported a position in EHC in Q3 2018 and held it in 9 quarters. The position peaked at $41.1M in Q4 2018. 437 funds tracked by Wall St. Rank hold EHC as of Q1 2024.

  • Robeco Institutional Asset Management reported no remaining Encompass Health position as of Q1 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 301 Encompass Health shares in Q1 2024, an estimated $20.1K.
  • Robeco Institutional Asset Management first reported a position in Encompass Health in Q3 2018 and held it in 9 quarters.
  • Robeco Institutional Asset Management's Encompass Health position peaked at $41.1M in Q4 2018.
  • 437 funds tracked by Wall St. Rank held Encompass Health as of Q1 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.